MicroRNA-16 inhibits bladder cancer proliferation by targeting Cyclin D1

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 7, 2013, Pages 4127-4130

  Jiang, Qi Quan ^a   Liu, Bin ^b   Yuan, Tao ^a  

^a TONGJI UNIVERSITY   (China)

^b SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Bladdercancer; Cell proliferation; Cyclin D1; MicroRNA 16

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CCND1 PROTEIN, HUMAN; CYCLIN D1; LUCIFERASE; MESSENGER RNA; MICRORNA; MIRN16 MICRORNA, HUMAN;

APOPTOSIS; ARTICLE; BLADDER TUMOR; CELL CYCLE; CELL PROLIFERATION; DRUG ANTAGONISM; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL CULTURE; WESTERN BLOTTING;

APOPTOSIS; BLOTTING, WESTERN; CELL CYCLE; CELL PROLIFERATION; CYCLIN D1; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUCIFERASES; MICRORNAS; OLIGONUCLEOTIDES, ANTISENSE; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED; URINARY BLADDER NEOPLASMS;

EID: 84885447603     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.7.4127     Document Type: Article

References (24)

1. Berezikov E (2011). Evolution of microRNA diversity and regulation in animals. Nat Rev Genet, 12, 846-60.
2. Dip N, Reis ST, Timoszczuk LS, et al (2012). Stage, grade and behavior of bladder urothelial carcinoma defined by the microRNA expression profile. J Urol, 188, 1951-6.
3. Esteller M (2011). Non-coding RNAs in human disease. Nat Rev Genet, 12, 861-74.
4. Hanlon K, Rudin CE, Harries LW (2009). Investigating the targets of MIR-15a and MIR-16-1 in patients with chronic lymphocytic leukemia (CLL). PLoS One, 4, e7169.
5. Hu Z, Lin Y, Chen H, et al (2013). MicroRNA-101 suppresses motility of bladder cancer cells by targeting c-Met. Biochem Biophys Res Commun, 435, 82-7.
6. Jacobs BL, Lee CT, Montie JE (2010). Bladder cancer in 2010: how far have we come? CA Cancer J Clin, 60, 244-72.
7. Linsley PS, Schelter J, Burchard J, et al (2007). Transcripts targeted by the microRNA-16 family cooperatively regulate cell cycle progression. Mol Cell Biol, 27, 2240-52.
8. Ma Q, Wang X, Li Z, et al (2013). microRNA-16 represses colorectal cancer cell growth in vitro by regulating the p53/survivin signaling pathway. Oncol Rep, 29, 1652-8.
9. Majid S, Dar AA, Saini S, et al (2012). MicroRNA-1280 inhibits invasion and metastasis by targeting ROCK1 in bladder cancer. PLoS One, 7, e46743.
10. Malmstrom PU, Loskog AS, Lindqvist CA, et al (2010). AdCD40L immunogene therapy for bladder carcinoma the first phase I/IIa trial. Clin Cancer Res, 16, 3279-87.
11. Neely LA, Rieger-Christ KM, Neto BS, et al (2010). A microRNA expression ratio defining the invasive phenotype in bladder tumors. Urol Oncol, 28, 39-48.
12. Noguchi S, Yasui Y, Iwasaki J, et al (2013) Replacement treatment with microRNA-143 and -145 induces synergistic inhibition of the growth of human bladder cancer cells by regulating PI3K/Akt and MAPK signaling pathways. Cancer Lett, 328, 353-61.
13. O'Kelly F, Marignol L, Meunier A, et al (2012). MicroRNAs as putative mediators of treatment response in prostate cancer. Nat Rev Urol, 9, 397-407.
14. Pasquinelli AE (2012). MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship. Nat Rev Genet, 13, 271-82.
15. Shimizu T, Suzuki H, Nojima M, et al (2013). Methylation of a Panel of MicroRNA Genes Is a Novel Biomarker for Detection of Bladder Cancer. Eur Urol, 63, 1091-100.
16. Song T, Zhang X, Zhang L, et al (2013). miR-708 promotes the development of bladder carcinoma via direct repression of Caspase-2. J Cancer Res Clin Oncol, 139, 1189-98.
17. Sun CY, She XM, Qin Y, et al (2013). miR-15a and miR-16 affect the angiogenesis of multiple myeloma by targeting VEGF. Carcinogenesis, 34, 426-35.
18. Takeshita F, Patrawala L, Osaki M, et al (2010). Systemic delivery of synthetic microRNA-16 inhibits the growth of metastatic prostate tumors via downregulation of multiple cell-cycle genes. Mol Ther, 18, 181-7.
19. van Kouwenhove M, Kedde M, Agami R (2011). MicroRNA regulation by RNA-binding proteins and its implications for cancer. Nat Rev Cancer, 11, 644-56.
20. Vardouli L, Lindqvist C, Vlahou K, et al (2009). Adenovirus delivery of human CD40 ligand gene confers direct therapeutic effects on carcinomas. Cancer Gene Ther, 16, 848-60.
21. Voutsinas GE, Stravopodis DJ (2009). Molecular targeting and gene delivery in bladder cancer therapy. J Buon, 14, S69-78.
22. Wang S, Xue S, Dai Y, et al (2012). Reduced expression of microRNA-100 confers unfavorable prognosis in patients with bladder cancer. Diagn Pathol, 7, 159.
23. Zhang X, Wan G, Mlotshwa S, et al (2010). Oncogenic Wip1 phosphatase is inhibited by miR-16 in the DNA damage signaling pathway. Cancer Res, 70, 7176-86.
24. Zhu DX, Miao KR, Fang C, et al (2011). Aberrant microRNA expression in Chinese patients with chronic lymphocytic leukemia. Leuk Res, 35, 730-4.